BEFORE YOU START
Sermorelin doctor finder
Check before you choose.
This plain-language guide helps you find and check care; it offers no directory of doctors.
THE SHORT ANSWER
Real drug.
Different rules now.
The Food and Drug Administration (FDA) reviews a medicine separately for each specific use.
In the United States, no sermorelin medicine with FDA approval is on sale as of September 28, 2026.
Compounding means making medicine to fill an order instead of supplying a finished, factory-made product.
What the name means
Sermorelin is made in a lab and belongs to a group called peptides. A peptide has protein building blocks linked into a short chain.
It tells a small gland called the pituitary to release its own growth hormone. The gland sits below the brain.
Children with too little growth hormone can have trouble growing.
It is not growth hormone itself.
Small studies in older adults found higher hormone levels; the studies that measured body fat found no drop in it.
Ask what benefit is expected for you, and which study supports it.
What the old approval covered
Sermorelin (Geref) once had FDA approval to test growth hormone release and treat poor growth in children with a growth hormone shortage.
Those approvals ended in 2009.
Sermorelin has no FDA approval for use in adults as of September 28, 2026.
Can a pharmacy make it?
Sermorelin acetate is the full name of the ingredient used in the old approved drug.
The word acetate matters because the pharmacy rules discussed here apply to that ingredient, not every version of sermorelin.
As of September 28, 2026, state-licensed pharmacies may make sermorelin acetate for an identified patient with a valid prescription.
The pharmacy still has to follow all other federal and state compounding rules.
The pharmacy may be able to make it under general rules, but that is not FDA permission naming sermorelin for an individual prescription.
Ask the pharmacy which rules let it make this exact medicine for you in your state.
Compounded sermorelin is not FDA-approved, even when made within the rules, as of September 28, 2026.
The FDA does not check a compounded product’s safety, quality or results before it reaches patients.
TAKE THE NEXT CHECK
Names. Reasons. A full bill.
Start with an in-person visit or telehealth, which means care at a distance. Ask about symptoms and options before choosing a treatment.